I see many posts about earnings. Yes earnings are of importance but not so much as reinvestment in product growth with a new and growing company. It is a solid practice recognized in the corporate world as positive. Defiantly a strange practice in OTC markets though. I would not expect huge gains in the first quarter out of toxic financing but the next 3 quarters showing continued growth and profits will land MYDX on NASDAQ assuredly if not partnered with a larger interest that can facilitate increased growth.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.